Skip to main content
Top
Published in: Neurology and Therapy 1/2022

Open Access 01-03-2022 | Cranial MRI | Case Report

Glial Fibrillary Acidic Protein (GFAP) Astrocytopathy Presenting as Mild Encephalopathy with Reversible Splenium Lesion

Authors: Charlotte Héraud, Nicolas Capet, Michaël Levraut, Robin Hattenberger, Véronique Bourg, Pierre Thomas, Lydiane Mondot, Christine Lebrun-Frenay

Published in: Neurology and Therapy | Issue 1/2022

Login to get access

Abstract

Introduction

Autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy is scarce and usually presents as meningoencephalomyelitis. Here, we offer the case of an atypical presentation of GFAP-astrocytopathy.

Case Presentation

We report the case of a 26-year-old woman admitted to our neurology department for a 3-week progressive and worsening neurologic picture, with secondary worsening. Initial imaging showed a Mild Encephalitis with Reversible Splenium of corpus callosum lesion (MERS). Full infectious and autoimmune workup then revealed positivity of GFAP antibodies, leading us to diagnose GFAP astrocytopathy.

Discussion

Our case is the first reported association between MERS and GFAP astrocytopathy in an adult patient. Clinical presentation of GFAP astrocytopathy usually includes various neurologic symptoms and can lead to misdiagnosis.
Literature
1.
go back to reference Kunchok A, Zekeridou A, McKeon A. Autoimmune glial fibrillary acidic protein astrocytopathy. Curr Opin Neurol. 2019;32(3):452–8.CrossRef Kunchok A, Zekeridou A, McKeon A. Autoimmune glial fibrillary acidic protein astrocytopathy. Curr Opin Neurol. 2019;32(3):452–8.CrossRef
2.
go back to reference Shan F, Long Y, Qiu W. Autoimmune glial fibrillary acidic protein astrocytopathy: a review of the literature. Front Immunol. 2018;5(9):2802.CrossRef Shan F, Long Y, Qiu W. Autoimmune glial fibrillary acidic protein astrocytopathy: a review of the literature. Front Immunol. 2018;5(9):2802.CrossRef
3.
go back to reference Oger V, Bost C, Salah L, Yazbeck E, Maurey H, et al. Mild encephalitis/encephalopathy with reversible splenial lesion syndrome: an unusual presentation of anti-GFAP astrocytopathy. Eur J Paediatr Neurol. 2020;26:89–91.CrossRef Oger V, Bost C, Salah L, Yazbeck E, Maurey H, et al. Mild encephalitis/encephalopathy with reversible splenial lesion syndrome: an unusual presentation of anti-GFAP astrocytopathy. Eur J Paediatr Neurol. 2020;26:89–91.CrossRef
4.
go back to reference Fang B, McKeon A, Hinson SR, Kryzer TJ, Pittock J, et al. Autoimmune glial fibrillary acidic protein astrocytopathy: a novel meningoencephalomyelitis. JAMA Neurol. 2016;73(11):1297–307.CrossRef Fang B, McKeon A, Hinson SR, Kryzer TJ, Pittock J, et al. Autoimmune glial fibrillary acidic protein astrocytopathy: a novel meningoencephalomyelitis. JAMA Neurol. 2016;73(11):1297–307.CrossRef
5.
go back to reference Ciron J, Sourdrille F, Biotti D, Tchoumi T, Ruiz A, et al. Area postrema syndrome: another feature of anti-GFAP encephalomyelitis. Mult Scler J. 2020;26(2):253–5.CrossRef Ciron J, Sourdrille F, Biotti D, Tchoumi T, Ruiz A, et al. Area postrema syndrome: another feature of anti-GFAP encephalomyelitis. Mult Scler J. 2020;26(2):253–5.CrossRef
6.
go back to reference Issa N, Martin C, Dulau C, Camou F. Severe anti-GFAP meningo-encephalomyelitis following viral infection. Mult Scler Relat Disord. 2020;45:102448.CrossRef Issa N, Martin C, Dulau C, Camou F. Severe anti-GFAP meningo-encephalomyelitis following viral infection. Mult Scler Relat Disord. 2020;45:102448.CrossRef
7.
go back to reference Heide E, Chaudhari A, Pirverdian A, Lai S, Courtney A. Failure of IVIG in steroid-responsive autoimmune glial fibrillary acidic protein astrocytopathy: a case report. Mult Scler Relat Disord. 2021;51:102933.CrossRef Heide E, Chaudhari A, Pirverdian A, Lai S, Courtney A. Failure of IVIG in steroid-responsive autoimmune glial fibrillary acidic protein astrocytopathy: a case report. Mult Scler Relat Disord. 2021;51:102933.CrossRef
Metadata
Title
Glial Fibrillary Acidic Protein (GFAP) Astrocytopathy Presenting as Mild Encephalopathy with Reversible Splenium Lesion
Authors
Charlotte Héraud
Nicolas Capet
Michaël Levraut
Robin Hattenberger
Véronique Bourg
Pierre Thomas
Lydiane Mondot
Christine Lebrun-Frenay
Publication date
01-03-2022
Publisher
Springer Healthcare
Published in
Neurology and Therapy / Issue 1/2022
Print ISSN: 2193-8253
Electronic ISSN: 2193-6536
DOI
https://doi.org/10.1007/s40120-021-00302-y

Other articles of this Issue 1/2022

Neurology and Therapy 1/2022 Go to the issue